News

Picking from the Red Book of the CHS: What's New in This Year's Recommendations for Diagnosis and Treatment of AML?
In recent years, there have been significant advances in the diagnosis and therapy of acute myeloid leukemia (AML). High-quality laboratory diagnostics (molecular genetics, cytogenetics, and flow cytometry) are absolutely essential, and monitoring measurable residual disease is becoming increasingly important. The range of treatment options is also beginning to expand. The content of the latest 'Recommendations for the Diagnosis and Treatment of Acute Myeloid Leukemia (AML),' which are part of this year's updated 'Red Book' of the Czech…

Educational Brochure for Patients with CLL

Bacterial Biofilm as a Complication of Respiratory Disease Treatment

Impact of erdostein on bacterial biofilm − and what it means for clinical practice?

Low Molecular Weight Heparin in an ECMO Patient − Case Study

Use of Enoxaparin in Patients After Implantation of Left Ventricular Assist Device

Prophylaxis with Enoxaparin After Total Knee or Hip Replacement

What Are the Impacts of Not Administering Extended VTE Prophylaxis in Oncology Patients After GIT Surgeries?

FEIBA in Real Clinical Practice – Fresh Data from the Observational Study FEIBA GO

Untreated Bleeding in Hemophilia A – An Underestimated Problem? To What Extent?
Conferences
News from the world of medicine
All conferences
Popular this week
- Shooting at the Faculty of Arts of Charles University and activation of the trauma plan at the First Surgical Clinic of the General Teaching Hospital
- BENIGN DERMATOSIS OF PENIS
- Does AI Evaluate Patients' Health More Accurately Than Doctors?
- Brain scans of patients with multiple sclerosis will be evaluated by AI
- How to Align Heart and Mind: The Brain of Lovers in Action